3D printed UV light cured polydimethylsiloxane devices for drug delivery. 2018

Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Tykistökatu 6A, Turku, FI-20520, Finland; Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014, Finland.

The goal of this work was to study the printability of PDMS with a semi-solid extrusion printer in combination with the UV-assisted crosslinking technology using UV-LED light to manufacture drug containing structures. Structures with different pore sizes and different drug loadings were prepared containing prednisolone as a model drug. The work showed that it was possible to print drug-free and drug-loaded drug delivery devices of PDMS with the 3D printing technique used in this study. The required UV-curing time to get sufficient crosslinking yield and mechanical strength was minimum three minutes. The microgram drug release from the printed structures was highest for the most drug loaded structures regardless of the porosity of the devices. By altering the surface area/volume ratio it was possible to print structures with differences in the release rate. This study shows that room-temperature semi-solid extrusion printing 3D printing technique in combination with UV-LED crosslinking is an applicable method in the production of prednisolone containing PDMS devices. Both the extrusion 3D printing and the UV-crosslinking was done at room temperature, which make this manufacturing method an interesting alternative for manufacturing controlled release devices containing temperature susceptible drugs.

UI MeSH Term Description Entries
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004129 Dimethylpolysiloxanes Silicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. They comprise a series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants, and liquids for drug vehicles; and as antifoaming agents. Dimethylsiloxanes,Polydimethylsiloxanes,Dimethylpolysiloxane,Dimethylsiloxane
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D013678 Technology, Pharmaceutical The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients. Technology, Pharmacy,Pharmaceutic Technology,Pharmaceutical Technology,Pharmacy Technology,Technology, Pharmaceutic
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray
D016062 Porosity Condition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance. Porosities
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D065546 Drug Liberation Release of drugs from DOSAGE FORMS into solution. Drug Dissolution,Drug Release,Dissolution, Drug,Liberation, Drug,Release, Drug
D066330 Printing, Three-Dimensional Process for making, building or constructing a physical object from a three-dimensional digital model by laying down many successive thin layers of building material. 3-D Printing,3-Dimensional Printing,3D Printing,Three-Dimensional Printing,3 D Printing,3 Dimensional Printing,3-D Printings,3-Dimensional Printings,3D Printings,Printing, 3-D,Printing, 3-Dimensional,Printing, 3D,Printing, Three Dimensional,Printings, 3-D,Printings, 3-Dimensional,Printings, 3D,Printings, Three-Dimensional,Three Dimensional Printing,Three-Dimensional Printings

Related Publications

Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
September 2017, Expert review of medical devices,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
December 2017, Journal of controlled release : official journal of the Controlled Release Society,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
December 2020, Pharmaceutics,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
October 2022, Journal of controlled release : official journal of the Controlled Release Society,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
August 2023, ACS omega,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
July 2023, Advanced drug delivery reviews,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
July 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
January 2023, International journal of bioprinting,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
June 2020, Micromachines,
Jenny Holländer, and Risto Hakala, and Jaakko Suominen, and Niko Moritz, and Jouko Yliruusi, and Niklas Sandler
May 2024, Biomaterials advances,
Copied contents to your clipboard!